M. Vijibala*, R. Karolin Daisy Rani, V. Velpandian and M. Pitchiah Kumar


Siddha formulations becomes popular cure as an ailment for treating several diseases throughout the globe, as a complementary and alternate medicine. Physicochemical evaluation of the preparation plays vital role in establishing the monograph of the formulation, as it becomes the documentary evidence to substantiate the standards of the preparation. It renders the useful information like genuinity, stability, selective characteristic feature and nature of the compound’s present in the drug. Siddha also have standardized protocols for purification and detoxification of certain phytocomponents used in specific formulations. As this will greatly reduce the toxicity and also enhance the therapeutic efficacy of the formulation. Through systematic standardization a formulator can profile the preparation with respect to the following (i) Physiochemical parameters (ii) Category of phytocomponents (iii) Nature of individual chemical component (iv) Structural and functional group analysis (v) Correlation of mechanism with respect to the functional group present in bioactive phytocomponents (vi) Drug stability (vii) Pharmacokinetic profiling (viii) Receptors on which the drug acts and ix) Chances of possible interaction. The main aim of the present investigation is to systematically purify, standardize and to carry out the Invitro antioxidant evaluation of the novel siddha preparation Sambirani Poo Kuligai (SPK) as per AYUSH regulations. The organoleptic character of the drug SPK justifies the purity of the formulation. The results obtained from the physicochemical evaluation revels that the total ash value of SPK was 79.62 %, loss on drying value is 13.62% in which water soluble ash value is 16.75% and acid insoluble ash was found to be 0.225% respectively. Phytochemical analysis reveals the presence of phytocomponents such as alkaloids, carbohydrates, glycosides, phytosterol, triterpenes, proteins and amino acids. Biochemical investigation of the test drug SPK reveals the presence of the following radicals such as calcium, magnesium, sodium and phosphate. HPTLC analysis of the SPK reveals the presence of 11 phytocomponents. In conclusion the trial drug SPK confirms the regulatory requirement and also possess significant phytocomponents such as phytosterols which contributes to the beneficial effect on polycystic ovarian syndrome (PCOS).

Keywords: Siddha, Standardization, Physicochemical, Sambirani Poo Kuligai, AYUSH regulations, HPTLC, PCOS.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    OCTOBER 2018 Issue has been successfully launched on 1 October 2018

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 4.382 to 4.918 due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction